Skip to content
Our reporters bring you news and highlights from BIO’s in-person and virtual events.
The FDA’s Accelerated Approval Pathway must be preserved against current threats as it has been a lifeline for patients with rare diseases, life-threatening conditions, […]
FDA Accelerated Approval Pathway must be preserved, experts say Read More »
The COVID-19 pandemic brought anxiety and uncertainty worldwide, and also created challenges from social isolation to supply chain issues to economic instability, which worsened
BIO Unbound: ‘Science is limitless when we limit science less’ Read More »
Asked what this pandemic taught us that will help us prepare for the next one, a panel of experts mentioned the need to improve
COVID lessons on manufacturing, distribution, regulation Read More »
The COVID-19 pandemic shook up the global health care system in ways that were more unique and acute than in years past. Yet, the
How do you get an entire population vaccinated and boosted? Read More »
About 50% of the world’s population are women – and women account for around 85% of spending decisions, said Cathy Friedman, Executive Venture Partner
Women’s health ‘woefully underfunded’ – but that’s changing Read More »
On Day 2, the Good Day BIO Live team brings you exclusive interviews with Johnson & Johnson’s Pierre Theodore, Travere Therapeutics’ Eric Dube, Organon’s Kevin Ali,
Good Day BIO LIVE! from San Diego – watch Tuesday’s episode Read More »
Biotechnology as a sector has a massive impact on Environmental, Social, and Governance (ESG) issues, but one area of growing importance to biotech is
Biotech has the power to impact ESG issues Read More »
Global health equity is a complex problem that impacts every country, and the biotech industry can be part of the solution, according to panelists
Biotech can be part of the solution to health inequity – here’s how Read More »
The biotechnology industry’s focus on diversity, equity, and inclusion (DEI) in recent years has brought about improvement, but we still have work to do,
Biotech leaders discuss how to build a more inclusive industry Read More »
The Biopharma Sustainability Roundtable published a guidance document which expands on strategic thinking and planning of biotechnology and pharma investor Environmental, Social, and Governance
How biopharma can better communicate about ESG Read More »
